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A novel lysozyme mutation Phe57Ile associated with heredi- protein A-II (apoA-II) [1–6]. Each type of amyloidosis
tary renal amyloidosis. is inherited as an autosomal-dominant disease and is
Background. Variant forms of lysozyme, a ubiquitous bacte- associated with a structurally altered protein that aggre-riolytic enzyme, are known to lead to hereditary non-neuro-
gates to form amyloid fibrils. These proteins may be thepathic renal amyloidosis and, so far, three different mutations
result of single nucleotide change, deletion, or insertionof the lysozyme gene have been reported. In this study, we
report a novel lysozyme variant, Phe57Ile, associated with renal in the gene coding for the amyloid precursor protein.
amyloidosis in three patients in one Italian Canadian family. Lysozyme is a ubiquitous bacteriolytic enzyme present
Methods. The proband was a 52-year-old woman who devel- in external secretions and in polymorphonuclear leuko-oped renal failure at the age of 42 years. Renal biopsy demon-
cytes and macrophages. Variant lysozyme is known tostrated replacement of glomeruli by amyloid. Her younger sister
cause non-neuropathic renal amyloidosis and, so far,and her younger daughter who underwent renal transplanta-
tion also had renal amyloidosis. The proband’s older daughter three mutations in the lysozyme gene, which are associ-
and her niece were in good health. To elucidate pathogenesis ated with renal amyloidosis, have been described [5, 7].
of this hereditary renal amyloidosis, DNA analyses of the lyso- Herein, we report a novel lysozyme variant (Phe57Ile)zyme gene, including single strand confirmation polymorphism,
associated with renal amyloidosis in a Caucasian family.direct DNA sequence, and restriction fragment length poly-
morphism analyses, were performed.
Results. DNA analyses of the lysozyme gene revealed a T to
CASE REPORT: THE PROBANDA transversion at the first position of codon 57 of the lysozyme
gene in the proband, her sister, and her affected and unaffected The proband (II-1 in Fig. 1) was a 52-year-old Italian
daughters, indicating a replacement of Phe by Ile at residue 57. Canadian woman. She had been in good health until age
In addition, DNA sequencing demonstrated a C to A transver-
of 39 years, and she developed renal failure at the agesion at the second position of codon 70, denoting a replacement
of 42 years. Renal biopsy demonstrated replacement ofof Thr by Asn at residue 70, in the proband’s sister and her
niece. Thus, the proband’s sister is compound heterozygous glomeruli by amyloid deposits with the characteristic
for the Phe57Ile and Thr70Asn alleles. green birefringence under polarized light with Congo
Conclusion. Distinctive clinical features in patients of this red staining (Fig. 2). Dialysis was initiated, and she under-
family are nephropathy due to renal amyloidosis. Our results
went renal transplantation at the age of 44 years. How-indicate that the novel lysozyme variant Phe57Ile is associated
ever, she developed ischemic heart disease in her latewith renal amyloidosis in this family. From our results, a clear
relation between the Thr70Asn polymorphism and renal amy- forties and she died of postoperative complications at the
loidosis could not be demonstrated. age of 52 years, following triple coronary bypass surgery.
She did not show any overt signs of hepatosplenomegaly,
neuropathy, amyloid cardiomyopathy, or skin petechiae.
Hereditary renal amyloidosis may be caused by muta- DNA analysis of a number of genes that are associated
tions in a number of amyloid precursor proteins, includ- with renal amyloidosis, including TTR, apoA-I, apoA-II,
ing transthyretin (TTR), apolipoprotein A-I (apoA-I), and fibrinogen A -chain failed to reveal any abnormali-
gelsolin, fibrinogen A -chain, lysozyme, and apolipo- ties. Her father (I-1 in Fig. 1) reportedly died of heart
attack at the age of 57. Her mother died of gastric cancer
Key words: hereditary amyloidosis, lysozyme variant, nephropathy, when she was in her 80s. Both parents came from large
polymorphism, compound heterozygosity. families, with no recognized history of renal failure.
A daughter (III-2 in Fig. 1) of the proband developedReceived for publication July 9, 2002
hypertension at the age of 17 years. A renal biopsy dem-and in revised form November 4, 2002
Accepted for publication December 10, 2002 onstrated severe amyloid deposition in glomeruli and
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Fig. 1. Pedigree and Tsp509 I restriction site
analysis of lysozyme exon 2 polymerase chain
reaction (PCR) products. Solid symbols de-
note affected patients and an inner solid circle
denotes an unaffected mutant gene (lysozyme
Phe57Ile) carrier. Asterisks indicate a carrier
of a Thr70Asn allele. An arrow indicates the
proband. In restriction fragment length poly-
morphism (RFLP) analysis, the T to A trans-
version at the first position of codon 57 of the
lysozyme gene creates a Tsp509 I restriction
site within the 236 bp exon2 PCR amplified
fragment. Enzyme digestion gives fragments
of 128 bp and 108 bp for the mutant allele.
The PCR-amplified fragments (236 bp) of the
proband (II-1), her affected sister (II-2), and
her unaffected (III-1) and affected daughter
(III-2) were incompletely digested, indicating
heterozygosity for the mutation. Abbrevia-
tions are: M, 100 bp molecular ruler DNA size
standard (Bio-Rad); C, normal control.
Fig. 2. Histopathologic findings of biopsied kidney of the proband showing amyloid deposition in glomeruli and vascular walls (arrows). (A)
Congo red staining. (B) Apple green birefringence typical of amyloid under polarized light.
22 years and underwent renal transplantation at the age (II-2), two daughters (III-1 and III-2), and her niece (III-3)
of 23 years. She has been well for 13 years. The oldest were isolated from peripheral blood leukocytes using
daughter of the proband (III-1), at the age of 42 years, standard phenol/chloroform method.
is clinically well. II-2, a younger sister of the proband
Single-strand conformation polymorphismhad proteinuria at the age of 35 years, although her blood
pressure was normal. Renal biopsy revealed amyloid (SSCP) analysis
deposition in glomeruli, vessel walls, and tubular base- All four exons of the lysozyme gene [8] were examined
ment membranes. She underwent renal transplantation by SSCP analysis using oligonucleotide primers as indi-
at the age of 43 years and has been in good health since cated in Table 1. Polymerase chain reaction (PCR) was
then. The proband’s niece (III-3) is clinically well at the
done in a total volume 50 L, containing 5 L of 10 age of 33 years.
PCR buffer (100 mmol/L Tris HCl, pH 8.3, 500 mmol/L
KCl, 12 mmol/L MgCl2), 8 L of 1.25 mmol/L desoxy-
METHODS nucleoside triphosphate (dNTP), 15 pmol of each primer,
DNA isolation 2.5 units of Taq polymerase (Sigma Chemical Co., St.
Louis, MO, USA) and 100 ng of genomic DNA. Ampli-After full informed consent was obtained, genomic
DNA samples of the proband (II-1), the proband’s sister fication was performed using a Perkin-Elmer Thermal
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Fig. 3. DNA sequence analysis of exon 2 of the lysozyme gene. Both thymine and adenine (arrows) are present at the first position of codon 57
of the lysozyme gene in the DNA sequence of the proband (II-1) and her affected sister (II-2). Furthermore, both cytosine and adenine (*) are
present at the second position of codon 70 in the proband’s sister (II-2) and her unaffected niece (III-3) who does not have the T to A transversion
at the first position of codon 57.
Table 1. Olignucleotide primers for human lysozyme geneCycler (Norwalk, CT, USA) for 35 cycles consisting of
denaturing at 94C for 1 minute, annealing at 60C for Lyz E1-1: 5-CAGTCA ACA TGA AGG CTC TCA T-3
Lyz E1-2: 5-GTT CCA TAC GTA GCT AAT TCT CT-31 minute, and extension at 72C for 1 minute. SSCP
Lyz E2-1: 5-CAC TTA GTG TTG CTG TTT ATT ACT-3analysis was performed using 6 L of the PCR product Lyz E2-2: 5-AGA TTG GTC AAA TAT TAG CTT GTC-3
as previously described [9]. Lyz E3-1: 5-ATT CCT TAC CAC CTG TCT TTC A-3
Lyz E3-2: 5-TGC TCT CAT TGT ATA TAT CAA CAG-3To confirm that the lysozyme Phe57Ile mutation is not
Lyz E4-1: 5-AAC CTT TCA CCA TTT GCT TCA TC-3
a polymorphism that is observed in healthy people, SSCP Lyz E4-2: 5-ATG TGA GAG AGA CAA AAT GAG CT-3
analysis of lysozyme exon 2 was performed on DNA
from 100 Caucasian volunteers.
Direct DNA sequencing and Lyz E2-2 presented in Table 1. PCR products were
Exon 2 of the lysozyme gene of the family members digested with the endonuclease Tsp509 I (New England
(II-1, II-2, III-1, III-2, and III-3), and exons 1, 3, and Biolabs, Beverly, MA, USA) at 65C for 4 hours, and
4 of III-1 and III-2 were examined by direct DNA se- then electrophoresed through a 3% (weight/volume)
quencing. PCR was done as indicated above. PCR prod- Nusieve GTG agarose gel (BMA, Rockland, ME, USA).
ucts were purified by QIAquick PCR Purification Kit
(Qiagen, Valencia, CA, USA) according to the manufac-
RESULTSture’s protocol. Sequencing reaction was performed by
using 1.0 L of purified PCR product as template and SSCP analysis of exon 2 of the lysozyme gene revealed
the Thermo Sequence [-33P]-ddNTP-Radiolabeled Ter- three patterns of abnormally migrating bands in the fam-
minator Cycle Sequencing Kit (USB Cleveland, OH, ily members compared to normal controls. One is seen
USA). Samples were electrophoresed on a 6% polyacryl- in the proband (II-1), her unaffected daughter (III-1),
amide gel with 7 mol/L urea at 45W for 3 hours using a and her affected daughter (III-2). The second pattern is
glycerol-tolerant gel buffer, dried, and exposed to Kodak seen in her affected sister (II-2). The third is seen in an
X-Omat film (Rochester, NY, USA). unaffected niece (III-3). No other abnormalities were
detected in exons 1, 3, and 4 by SSCP analysis. Direct
Restriction fragment length polymorphism DNA sequencing of exon 2 in the proband (II-1) showed
(RFLP) analysis a single base transversion at the first nucleotide of codon
57 in the lysozyme gene [8] (TTT to ATT), indicating aA 236 bp subsequence of exon 2 of the lysozyme gene
was amplified using oligonucleotide primers Lyz E2-1 replacement of Phe by Ile at residue 57 (Fig. 3). This
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Table 2. Five kindreds with lysozyme amyloidosis
Families 1 2 3 4 5
Mutation (exon) His56Thr (exon 2) Phe57Ile (exon 2) Trp64Arg (exon 2) Asp67His (exon 2) Asp67His (exon 2)
Ethnic background English Italian French English English
Residence UK Canada France UK UK
Clinical features Nephropathy, petechiae Nephropathy Nephropathy, intestinal Nephropathy, GI Liver rupture
obstruction, Sicca bleeding
syndrome
Organs where Kidney, liver, spleen, Kidney Kidney, GI tract, Kidney, liver, spleen, Liver, spleen, lymph
amyloid deposits skin, lymph nodes salivary glands GI tract nodes, rectum
were proven
Reference [5, 12] Present study [7] [5, 13, 14] [11]
GI stands for gastrointestinal.
nucleotide change was detected in the proband’s daugh- able clinical manifestation was nephropathy caused by
renal amyloidosis. In particular, the distinctive featureters (III-1 and III-2) and her sister (II-2). In addition,
of amyloidosis in this family is that affected individualsDNA sequencing showed a single base transversion at
do not have significant dysfunction due to amyloid depo-the second position of codon 70 (ACC to AAC), indicat-
sition in other visceral organs, including the heart, liver,ing a replacement of Thr by Asn at residue 70 in the
spleen, peripheral nerve, and skin.proband’s sister (II-2) and her niece (III-3). Other muta-
Amyloidosis associated with lysozyme mutations is ations were not seen in exons 1, 3, and 4 of III-1 or III-2
very rare autosomal-dominant disorder; only four fami-by the DNA sequence analysis, consistent with the result
lies have been so far reported [5, 7, 11]. Two lysozymeof SSCP analysis (data not shown).
mutations (Ile56Thr and Asp67His) were first describedRFLP analysis of the 236 bp PCR product from
in two English kindreds in 1993 [5], and since then, anLyzE2-1 and LyzE2-2 primers revealed that the proband
additional mutation (Trp64Arg) has been reported inhad the Tsp509 I recognition site associated with the T
a French family [7]. A cardinal clinical feature of theto A mutation at the first position of codon 57 of the
amyloidosis caused by these three mutations is nephrop-lysozyme gene. Electrophoresis of the digested PCR
athy due to amyloid deposition in kidney and peripheralproduct in the proband (II-1), her daughters (III-1 and
neuropathy is not noticeable. The clinical phenotype,III-2), and sister (II-2) gave bands of 128 bp and 108
however, may be variable with each lysozyme mutationbp in addition to the normal 236 bp band, indicating
or even with the same mutation (Table 2). With the lyso-heterozygosity for the Phe57Ile mutation (Fig. 1).
zyme Ile56Thr mutation [5, 12], all patients had skin pe-By SSCP analysis of exon 2 lysozyme gene in 100
techiae in addition to nephropathy, and with Trp64Argunrelated persons (200 alleles), 12 persons had the ab-
[7], intestinal obstruction and sicca syndrome were shown.normal migration pattern as seen in the proband’s niece
In lysozyme Asp67His, the clinical pictures were sharply(III-3). Direct DNA sequence analysis of exon 2 lyso-
different between the first reported family and the sec-zyme gene revealed that none of these 12 persons had the
ond reported family [11]. In the first reported family withPhe57Ile mutation. All of them were heterozygous for
the Asp67His variant, patients had few clinical symptomsACC (Thr) and AAC (Asn) at codon 70 (data not shown).
related to liver and spleen dysfunction [5, 13, 14]. None-Therefore, the allele frequency of Thr70Asn of lysozyme
theless, they had marked hepatic and splenic amyloidosisgene in this study was 6.0% (12 alleles/200 alleles).
[5, 13, 14]. On the other hand, in the second reported fam-
ily, all three affected members in three generations pre-
DISCUSSION sented with massive hepatic hemorrhage due to hepatic
Hereditary renal and nonneuropathic amyloidosis is amyloid deposition between the ages of 15 and 50 years
known as Ostertag type amyloidosis [10], and, by recent [11]. Of interest is that no patients in this family had
molecular and biochemical techniques, the pathogenesis renal amyloidosis on histopathologic examination [11].
of this type of amyloidosis has been gradually elucidated. Our results showed that two members (II-2 and III-3)
To date, several types of amyloidosis, including fibrino- of the family presented here have a Thr70Asn allele and
gen A -chain, lysozyme, and apoA-II have been shown the proband’s affected sister (II-2) is compound hetero-
to cause this Ostertag-type amyloidosis. zygous for the Phe57Ile variant allele and the Thr70Asn
In the present study, our results indicate that renal allele. Lysozyme Thr70Asn substitution reported by Booth
amyloidosis in this kindred is associated with the newly et al [15, 16] is now recognized as a polymorphism in
discovered lysozyme mutation Phe57Ile. During the clin- the lysozyme gene. Although it is hypothesized that the
hydrogen bonds in the lysozyme molecule that make anical courses of all patients in this family, the most notice-
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important contribution to the stability of the -domain variants were less stable with respect to denaturation
than wild-type lysozyme [17, 21]. Thus Booth et al [17]would be disturbed in both the Thr70Asn substitution
and in the Asp67His variant [15–17], a relationship be- suggested that partly folded intermediates, which were
described as “molten globule-like form” are involved intween the Thr70Asn polymorphism and amyloid fibril
formation has not been demonstrated. Additionally, in fibrillogenesis. On the other hand, Canet et al [22] sug-
gested that the mechanisms causing the instability of thesemany genetic disorders, some polymorphisms are known
to play a very important role in severity of the disease. lysozyme variants could be different from each other.
The location of substitution of the Ile56Thr in the variantIn TTR amyloidosis, some polymorphisms of the TTR
gene were known to have an impact on the clinical phe- lysozyme is at the base of -domain, which has an influ-
ence on the folding of the -domain [22]. The locationnotype. While Terazaki et al [18], reported a compound
heterozygous patient with TTR Val30Met and Arg104His, of the His67Asp in the variant lysozyme is in an outer
loop of the -domain, which gains native structure onlythe clinical picture of that patient was significantly milder
than that of patients with TTR Val30Met and wild-type toward the end of the refolding process [22]. Hence, Ca-
net et al [22] suggested that, in the Ile56Thr variant, theTTR in the same family [18]. Moreover, it was recently
reported that TTR Thr119Met molecules increase the origin of the instability of the intermediates is primarily
caused by a reduction in the folding rate, compared tostability of the TTR tetramer with TTR Val30Met mole-
cules compared to the tetramer composed of TTR Val30- an increase in the unfolding rate in the Asp67His vari-
ant, which is 160 times greater than that of the wild-Met and wild-type TTR [19]. However, in the study de-
scribed herein, the clinical picture of the proband’s sister type. Therefore, the mechanism of amyloidogenesis in
the Phe57Ile may be similar to that in the Ile56Thr vari-(II-2) was almost the same as that of proband. Further-
more, the proband’s niece (III-3), who carries the ant, as suggested above [22], since the Phe57Ile variant
is also located at the base of the -domain.Thr70Asn allele, inherited it from her mother (II-2) and
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